{"id":49907,"date":"2020-02-19T11:54:51","date_gmt":"2020-02-19T09:54:51","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=49907"},"modified":"2020-02-19T11:54:51","modified_gmt":"2020-02-19T09:54:51","slug":"circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/","title":{"rendered":"Circular Farmac\u00e9utica: Ya disponible la edici\u00f3n del 3r cuatrimestre"},"content":{"rendered":"<p>Ya se puede acceder a un <strong>nuevo n\u00famero de la Circular Farmac\u00e9utica<\/strong>, la publicaci\u00f3n cient\u00edfica <strong>que edita el Colegio<\/strong>.<\/p>\n<p>En esta nueva edici\u00f3n <strong>destacamos<\/strong> los siguientes temas:<\/p>\n<ul>\n<li>El tratamiento de la <strong>deshabituaci\u00f3n de analg\u00e9sicos opioides<\/strong><\/li>\n<li>La <strong>C\u00farcuma<\/strong>: de la especie culinaria a <strong>la especie medicinal<\/strong><\/li>\n<li>El <strong>triple whammy<\/strong> y el riesgo <strong>de insuficiencia renal aguda<\/strong><\/li>\n<\/ul>\n<div class=\"destacat-blog\">\n<p>\u00c9ste es el contenido del <strong><a href=\"https:\/\/www.cofb.org\/es\/documents\/10136\/1070698\/Circular77-1.pdf\/4fe2477e-7c91-4de2-bce3-e979b3e6e720\/\" target=\"_blank\" rel=\"noopener\">n\u00famero Vuelo. 77, n\u00fam. 3, tercer cuatrimestre 2019<\/a>:<\/strong><\/p>\n<p><a href=\"https:\/\/www.cofb.org\/es\/documents\/10136\/1070698\/Circular77-3.pdf\/0884cdce-320c-451f-b15b-3f9fdbb3150f\/\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-49919 size-full\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/02\/Circular-farmac\u00e8utuica.bmp\" alt=\"\" width=\"692\" height=\"913\" \/><\/a><\/p>\n<ul>\n<li><strong>Editorial: <\/strong>T. Casas\u00edn.<\/li>\n<li><strong>Farmacoterapia: <\/strong>El \u201cTriple whammy\u201d y el riesgo de insuficiencia renal aguda; Tratamiento de la deshabituaci\u00f3n de analg\u00e9sicos opioides; Estado actual de la investigaci\u00f3n en torno al problema de la \u201cno iniciaci\u00f3n\u201d, a nivel mundial y en Catalu\u00f1a; Infusiones extendidas y continuas de antibi\u00f3ticos para alcanzar los objetivos PK\/PD de antibi\u00f3ticos y optimizar los resultados en eficacia y seguridad; Prostatitis por enterococcus faecalis.<\/li>\n<li><strong id=\"yui_patched_v3_11_0_1_1582113073839_1090\">El CIM informa:\u00a0<\/strong>La queratosis act\u00ednica.<\/li>\n<li><strong id=\"yui_patched_v3_11_0_1_1582113073839_1104\">Casos cl\u00ednicos:<\/strong>\u00a0Tratamiento de una infecci\u00f3n de reservorio Ommaya en un paciente pedi\u00e1trico; Paciente cr\u00edtico con infecciones m\u00faltiples; SIADH central por nocardiosis pulmonar con diseminaci\u00f3n cerebral en paciente inmunocompetente.<\/li>\n<li><strong id=\"yui_patched_v3_11_0_1_1582113073839_1121\">La Farmacia al d\u00eda:\u00a0<\/strong>Oficina de farmacia, dudas fuera (I).<\/li>\n<li><strong><strong id=\"yui_patched_v3_11_0_1_1582113073839_1138\">Salud P\u00fablica:<\/strong>\u00a0<\/strong>Crisis sanitaria por la aparici\u00f3n repentina de reci\u00e9n nacidos con \u201cs\u00edndrome del hombre lobo\u201d, el verano de 2019<\/li>\n<li><strong><strong id=\"yui_patched_v3_11_0_1_1582113073839_1154\">Alimentaci\u00f3n y nutrici\u00f3n:<\/strong>\u00a0<\/strong>Lactancia materna, \u00bfqu\u00e9 podemos hacer los farmac\u00e9uticos?<\/li>\n<li><strong id=\"yui_patched_v3_11_0_1_1582113073839_1170\">Plantas Medicinales:<\/strong>\u00a0C\u00farcuma: de especie culinaria a especie medicinal<\/li>\n<li><strong id=\"yui_patched_v3_11_0_1_1582113073839_1188\">Farmac\u00e9uticos innovadores<\/strong><\/li>\n<li><strong id=\"yui_patched_v3_11_0_1_1582113073839_1043\">Vadem\u00e9cum Cultural<\/strong><\/li>\n<\/ul>\n<\/div>\n<div class=\"box info\"><\/div>\n<h2><strong>\u00bfQuieres publicar en la Circular Farmac\u00e9utica?<\/strong><\/h2>\n<p><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/06\/circu.jpg\"><img decoding=\"async\" class=\"aligncenter size-full wp-image-46297\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/06\/circu.jpg\" alt=\"\" width=\"512\" height=\"205\" \/><\/a><\/p>\n<p><strong>An\u00edmate a reflexionar, pensar, dise\u00f1ar y emprender un estudio, una actividad, una revisi\u00f3n de un nuevo medicamento y valoraremos su publicaci\u00f3n en nuestra revista.<\/strong><br \/>\nSi es de tu inter\u00e9s,\u00a0<strong>contacta con formacio@cofb.net<\/strong>\u00a0y estudiaremos tu propuesta.<\/p>\n<\/div>\n<p><a href=\"https:\/\/www.cofb.org\/es\/colegi\/publicacions\/circular-farmaceutica\/\" target=\"_blank\" rel=\"noopener\"><strong>Ver n\u00fameros anteriores de Circular Farmac\u00e9utica<\/strong><\/a>\u00a0(v\u00eda cofb.org \u2013 en formato PDF)<\/p>","protected":false},"excerpt":{"rendered":"<p>Ya se puede acceder a un nuevo n\u00famero de la Circular Farmac\u00e9utica, la publicaci\u00f3n cient\u00edfica que edita el Colegio. En esta nueva edici\u00f3n destacamos los siguientes temas: El tratamiento de la deshabituaci\u00f3n de analg\u00e9sicos opioides La C\u00farcuma: de la especie culinaria a la especie medicinal El triple whammy y el riesgo de insuficiencia renal [\u2026]<\/p>","protected":false},"author":1,"featured_media":50014,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[269,88,89,2841,3926,3927,256,3928,2197,3929,3930,76,3931,3932,360,2149,3933,844,845,96,3934,3935,3936],"class_list":["post-49907","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-antibiotics","tag-casos-clinics","tag-circular-farmaceutica","tag-curcuma","tag-deshabituacio","tag-deshabituacio-danalgesics-opioides","tag-infeccio","tag-infusions-esteses","tag-insuficiencia-renal","tag-insuficiencia-renal-aguda","tag-lactancia-materna","tag-oficina-de-farmacia","tag-prostata","tag-prostatitis","tag-publicacio-cientifica","tag-publicacions","tag-queriatosi-actinica","tag-recerca","tag-revista","tag-salut-publica","tag-siadh","tag-sindrome-de-lhome-llop","tag-triple-whammy"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Circular Farmac\u00e8utica: Ja disponible l&#039;edici\u00f3 del 3r quadrimestre - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"Ja es pot accedir al nou n\u00famero de la Circular Farmac\u00e8utica, la publicaci\u00f3 cient\u00edfica que edita el Col\u00b7legi. En aquesta nova edici\u00f3 destaquem els seg\u00fcents temes: Tractament de la deshabituaci\u00f3 d&#039;analg\u00e8sics opioides; C\u00farcuma: de l&#039;esp\u00e8cie culin\u00e0ria a l&#039;esp\u00e8cie medicinal; Triple Whammy i risc d&#039;insufici\u00e8ncia renal aguda.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Circular Farmac\u00e8utica: Ja disponible l&#039;edici\u00f3 del 3r quadrimestre - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Ja es pot accedir al nou n\u00famero de la Circular Farmac\u00e8utica, la publicaci\u00f3 cient\u00edfica que edita el Col\u00b7legi. En aquesta nova edici\u00f3 destaquem els seg\u00fcents temes: Tractament de la deshabituaci\u00f3 d&#039;analg\u00e8sics opioides; C\u00farcuma: de l&#039;esp\u00e8cie culin\u00e0ria a l&#039;esp\u00e8cie medicinal; Triple Whammy i risc d&#039;insufici\u00e8ncia renal aguda.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-02-19T09:54:51+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Circular Farmac\u00e8utica: Ja disponible l&#8217;edici\u00f3 del 3r quadrimestre\",\"datePublished\":\"2020-02-19T09:54:51+00:00\",\"dateModified\":\"2020-02-19T09:54:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/\"},\"wordCount\":336,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"antibi\u00f2tics\",\"casos cl\u00ednics\",\"Circular Farmac\u00e8utica\",\"c\u00farcuma\",\"Deshabituaci\u00f3\",\"deshabituaci\u00f3 d'analg\u00e8sics opi\u00f2ides\",\"infecci\u00f3\",\"infusions esteses\",\"insufici\u00e8ncia renal\",\"insufici\u00e8ncia renal aguda\",\"lact\u00e0ncia materna\",\"Oficina de farm\u00e0cia\",\"pr\u00f2stata\",\"prostatitis\",\"publicaci\u00f3 cient\u00edfica\",\"Publicacions\",\"queriatosi act\u00ednica\",\"Recerca\",\"revista\",\"Salut p\u00fablica\",\"SIADH\",\"s\u00edndrome de l'home llop\",\"triple whammy\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/\",\"name\":\"Circular Farmac\u00e8utica: Ja disponible l'edici\u00f3 del 3r quadrimestre - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2020-02-19T09:54:51+00:00\",\"dateModified\":\"2020-02-19T09:54:51+00:00\",\"description\":\"Ja es pot accedir al nou n\u00famero de la Circular Farmac\u00e8utica, la publicaci\u00f3 cient\u00edfica que edita el Col\u00b7legi. En aquesta nova edici\u00f3 destaquem els seg\u00fcents temes: Tractament de la deshabituaci\u00f3 d'analg\u00e8sics opioides; C\u00farcuma: de l'esp\u00e8cie culin\u00e0ria a l'esp\u00e8cie medicinal; Triple Whammy i risc d'insufici\u00e8ncia renal aguda.\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Circular Farmac\u00e8utica: Ja disponible l&#8217;edici\u00f3 del 3r quadrimestre\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Circular Farmac\u00e8utica: Ja disponible l'edici\u00f3 del 3r quadrimestre - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"Ja es pot accedir al nou n\u00famero de la Circular Farmac\u00e8utica, la publicaci\u00f3 cient\u00edfica que edita el Col\u00b7legi. En aquesta nova edici\u00f3 destaquem els seg\u00fcents temes: Tractament de la deshabituaci\u00f3 d'analg\u00e8sics opioides; C\u00farcuma: de l'esp\u00e8cie culin\u00e0ria a l'esp\u00e8cie medicinal; Triple Whammy i risc d'insufici\u00e8ncia renal aguda.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/","og_locale":"es_ES","og_type":"article","og_title":"Circular Farmac\u00e8utica: Ja disponible l'edici\u00f3 del 3r quadrimestre - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"Ja es pot accedir al nou n\u00famero de la Circular Farmac\u00e8utica, la publicaci\u00f3 cient\u00edfica que edita el Col\u00b7legi. En aquesta nova edici\u00f3 destaquem els seg\u00fcents temes: Tractament de la deshabituaci\u00f3 d'analg\u00e8sics opioides; C\u00farcuma: de l'esp\u00e8cie culin\u00e0ria a l'esp\u00e8cie medicinal; Triple Whammy i risc d'insufici\u00e8ncia renal aguda.","og_url":"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2020-02-19T09:54:51+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Circular Farmac\u00e8utica: Ja disponible l&#8217;edici\u00f3 del 3r quadrimestre","datePublished":"2020-02-19T09:54:51+00:00","dateModified":"2020-02-19T09:54:51+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/"},"wordCount":336,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/#primaryimage"},"thumbnailUrl":"","keywords":["antibi\u00f2tics","casos cl\u00ednics","Circular Farmac\u00e8utica","c\u00farcuma","Deshabituaci\u00f3","deshabituaci\u00f3 d'analg\u00e8sics opi\u00f2ides","infecci\u00f3","infusions esteses","insufici\u00e8ncia renal","insufici\u00e8ncia renal aguda","lact\u00e0ncia materna","Oficina de farm\u00e0cia","pr\u00f2stata","prostatitis","publicaci\u00f3 cient\u00edfica","Publicacions","queriatosi act\u00ednica","Recerca","revista","Salut p\u00fablica","SIADH","s\u00edndrome de l'home llop","triple whammy"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/","url":"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/","name":"Circular Farmac\u00e8utica: Ja disponible l'edici\u00f3 del 3r quadrimestre - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/#primaryimage"},"thumbnailUrl":"","datePublished":"2020-02-19T09:54:51+00:00","dateModified":"2020-02-19T09:54:51+00:00","description":"Ja es pot accedir al nou n\u00famero de la Circular Farmac\u00e8utica, la publicaci\u00f3 cient\u00edfica que edita el Col\u00b7legi. En aquesta nova edici\u00f3 destaquem els seg\u00fcents temes: Tractament de la deshabituaci\u00f3 d'analg\u00e8sics opioides; C\u00farcuma: de l'esp\u00e8cie culin\u00e0ria a l'esp\u00e8cie medicinal; Triple Whammy i risc d'insufici\u00e8ncia renal aguda.","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2020\/02\/19\/circular-farmaceutica-ja-disponible-ledicio-del-3r-quadrimestre\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Circular Farmac\u00e8utica: Ja disponible l&#8217;edici\u00f3 del 3r quadrimestre"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Ja es pot accedir a un nou n\u00famero de la Circular Farmac\u00e8utica, la publicaci\u00f3 cient\u00edfica que edita el Col\u00b7legi. En aquesta nova edici\u00f3 destaquem els seg\u00fcents temes: El tractament de la deshabituaci\u00f3 d&#8217;analg\u00e8sics opioides La C\u00farcuma: de l&#8217;esp\u00e8cie culin\u00e0ria a l&#8217;esp\u00e8cie medicinal El triple whammy i el risc d&#8217;insufici\u00e8ncia renal [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/49907","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=49907"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/49907\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=49907"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=49907"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=49907"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}